Protein Variants | Comment | Organism |
---|---|---|
C320A | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320D | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320F | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320K | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320L | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320Q | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320S | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320T | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320W | mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
C320Y | A3DE catalytic activity is significantly increased which in turn increases antiviral activity by more than 20fold | Homo sapiens |
C320Y/E264Q | insertion of E264Q mutation completely disrupts C320Y activity, virion packaging capability is not impaired. Thus, the activity of C320Y does require an active cytidine deaminase | Homo sapiens |
DELTA307 | mutant shows disrupted anti-HIV activity | Homo sapiens |
DELTA320 | deletion mutant shows anti-HIV-1 activity comparable to wild-type | Homo sapiens |
Y307A | mutant shows disrupted anti-HIV activity | Homo sapiens |
Y307C | mutant shows disrupted anti-HIV activity | Homo sapiens |
Y307K | mutant shows disrupted anti-HIV activity | Homo sapiens |
Y307R | mutant shows disrupted anti-HIV activity | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
A3DE | - |
Homo sapiens |
APOBEC3 | - |
Homo sapiens |